title: Improved renal perfusion prevents disease progression in focal segmental glomerulosclerosis.
authors.forename: P
authors.initials: P
authors.lastname: Futrakul
authors.forename: N
authors.initials: N
authors.lastname: Futrakul
authors.forename: V
authors.initials: V
authors.lastname: Sitprija
authors.forename: R
authors.initials: R
authors.lastname: Sensirivatana
authors.forename: D
authors.initials: D
authors.lastname: Watana
authors.forename: P
authors.initials: P
authors.lastname: Kingwatanakul
mesh_terms: D017315:Cilazapril / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D018450:Disease Progression; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy* / Q000503:physiopathology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D017275:Isradipine / Q000627:therapeutic use; D010477:Perfusion; D011239:Prednisolone / Q000627:therapeutic use; D012079:Renal Circulation / Q000187:drug effects*
chemical_list: D017315:Cilazapril; D004176:Dipyridamole; D006493:Heparin; D011239:Prednisolone; D017275:Isradipine